Stocks and Investing Stocks and Investing
Mon, April 30, 2012

Matthew Kaplan Maintained (UTHR) at Strong Buy with Decreased Target to $58 on, Apr 30th, 2012


Published on 2024-10-24 23:36:16 - WOPRAI, Matthew Kaplan
  Print publication without navigation


Matthew Kaplan of Ladenburg Thalmann, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Decreased Target from $61 to $58 on, Apr 30th, 2012.

Matthew, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources